coronary artery disease
Biobanks have been making strides in gathering data from more diverse populations this year while the evidence for the clinical utility of embryo PRS testing remains insufficient.
PlaqueTec Raises $8M in Private Financing
The UK-based company is developing a bioinformatics platform to identify in vivo biomarkers of coronary artery disease to enable personalized treatments.
Combination of Polygenic, Social, Clinical Factors Improve Prediction of Heart Disease Risk
A model of these three measures improved heart disease risk predictions over any one measure, researchers reported at the American College of Cardiology meeting.
Polygenic Risk Score, AI Tool May Help Patients Reduce Inherited Heart Disease Risk, Study Suggests
Premium
University of Cambridge researchers said at the American College of Cardiology annual meeting that they plan to make the PRS and AI tool publicly available through an online app.
Cardiac-Related Consequences of Alcohol Flushing Genetic Variant Reduced by Drug
With endothelial cells derived from induced pluripotent stem cells, researchers tracked functional changes and potential treatment targets in alcohol flushing variant carriers.